Sandra Peterson

Sandra E.
Peterson is currently Chairman at Cynosure LLC, Aster Insights, Cynosure, Inc. (Massachusetts), and Executive Chairman at Volastra Therapeutics, Inc. since 2019.
She serves as Lead Independent Director at Microsoft Corp.
since 2023 and Director at the Institute for Advanced Study since 2015.
Other current roles include Director at Lotus Parent, Inc. and M2gen Holdings LP, Independent Director at Seaport Therapeutics, Inc. since 2024, Trustee at American Academy in Berlin GmbH since 2013, Member at Women's Forum, Inc. and C200 Foundation, and Operating Partner at Clayton Dubilier & Rice LLC since 2019.
Former positions include Chief Executive Officer at Bayer Medical Care, Inc., Chief Executive Officer at Bayer CropScience AG in 2012, Chairman-Worldwide Group at Johnson & Johnson from 2012 to 2018, Chairman at EcoHealth Alliance, Inc., Director at Handleman Co. from 2001 to 2005, Independent Director at The Dun & Bradstreet Corp.
from 2011 to 2015, Independent Director at Covetrus, Inc. from 2020 to 2022, Independent Director at Zymergen, Inc. from 2019 to 2021, Group President-Government at Medco Health Solutions, Inc. from 2003 to 2004, Executive VP & President-Medical Care at Bayer Healthcare LLC from 2009 to 2010, Senior Vice President-Marketing at Merck-Medco Managed Care LLC from 1999 to 2001, Member-Management Board at Bayer HealthCare AG, Member at Women Corporate Directors, and President at Bayer Diabetes Care.
Education includes undergraduate studies at Cornell University and graduate studies at Princeton University.